Pancreatic Cancer Research

ResearcherFudan UniversityNo recent work listed

Wentao Zhou

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-9806-2637; OpenAlex author ID A5101829164. Sources: OpenAlex.

Their work

Papers
6 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
21
Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: 2 papers · 2020: 1 paper · 2021: 1 paper · 2022: none · 2023: 1 paper

Papers 6

  1. PPDPF Promotes the Development of Mutant KRAS-Driven Pancreatic Ductal Adenocarcinoma by Regulating the GEF Activity of SOS1. Co-author DOI 10.1002/advs.202202448↗
  2. Upregulated circRNA hsa_circ_0071036 promotes tumourigenesis of pancreatic cancer by sponging miR-489 and predicts unfavorable characteristics and prognosis. Co-author DOI 10.1080/15384101.2021.1874684↗
  3. Current Role of Surgery in Pancreatic Cancer With Synchronous Liver Metastasis. Co-author DOI 10.1177/1073274820976593↗
  4. Exosomal miRNA-106b from cancer-associated fibroblast promotes gemcitabine resistance in pancreatic cancer. First author DOI 10.1016/j.yexcr.2019.111543↗
  5. Laparoscopic versus open pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: a propensity score matching analysis. Co-author DOI 10.1186/s40880-019-0410-8↗
  6. SF3B4 is decreased in pancreatic cancer and inhibits the growth and migration of cancer cells. Co-author DOI 10.1177/1010428317695913↗

Closest collaborators

The 21 strongest of 21 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Wenhui Lou · 4 shared papers, 2019–2021 · strength 0.51
  2. Dansong Wang · 4 shared papers, 2017–2020 · strength 0.44
  3. Yefei Rong · 3 shared papers, 2017–2021 · strength 0.30
  4. Tiantao Kuang · 3 shared papers, 2017–2019 · strength 0.25
  5. Yuan Fang · 2 shared papers, 2019–2021 · strength 0.23
  6. Xuefeng Xu · 2 shared papers, 2019 · strength 0.19
  7. Wenchuan Wu · 2 shared papers, 2019 · strength 0.19
  8. Jianang Li · 1 shared paper, 2021 · strength 0.13
  9. Xu Han · 1 shared paper, 2021 · strength 0.13
  10. Yaolin Xu · 1 shared paper, 2021 · strength 0.13
  11. Xiao‐Fan Wang · 1 shared paper, 2023 · strength 0.12
  12. Wei Chen · 1 shared paper, 2023 · strength 0.12
  13. Qian‐Zhi Ni · 1 shared paper, 2023 · strength 0.12
  14. Jing‐Jing Li · 1 shared paper, 2023 · strength 0.12
  15. Shuqun Cheng · 1 shared paper, 2023 · strength 0.12
  16. Dayong Jin · 1 shared paper, 2019 · strength 0.09
  17. Yucheng Zhou · 1 shared paper, 2019 · strength 0.09
  18. Chao Lu · 1 shared paper, 2019 · strength 0.09
  19. Weiwei Jin · 1 shared paper, 2019 · strength 0.09
  20. Yiping Mou · 1 shared paper, 2019 · strength 0.09
  21. Wenhui Lou · 1 shared paper, 2017 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.